SCHEMBL8325838

SCHEMBL8325838

CCCCOc1cccc(Nc2nccc(-c3c(C)[nH]c(C(=O)OC(C)(C)C)c3C)n2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 10/20 0.49
CDK4 P11802 9/20 0.49
JAK2 O60674 4/20 0.44
HDAC1 Q13547 3/20 0.44
HDAC6 Q9UBN7 3/20 0.44
EIF2AK2 P19525 2/20 0.43
PIK3CA P42336 1/20 0.41
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41
EGFR P00533 2/20 0.41
ITK Q08881 1/20 0.41
ABL1 P00519 3/20 0.41
SRC P12931 2/20 0.41
PRKCA P17252 2/20 0.41
PRKCD Q05655 2/20 0.41
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
BCR P11274 2/20 0.40
CDC7 O00311 1/20 0.40
PLK4 O00444 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8326117 0.91 CDK2 (0.51) CDK2CDK4JAK2HDAC1HDAC6
SCHEMBL8324386 0.89 CDK2 (0.52) CDK2CDK4JAK2EIF2AK2PIK3CA
SCHEMBL14011226 0.88 SYK (0.51) CDK2CDK4HDAC1HDAC6EIF2AK2
SCHEMBL8324838 0.85 EIF2AK2 (0.60) CDK2CDK4EIF2AK2PIK3CAPIK3CB
SCHEMBL8316906 0.84 CDK4 (0.58) CDK2CDK4JAK2EIF2AK2CDC7
SCHEMBL8320327 0.81 JAK2 (0.45) CDK2CDK4JAK2HDAC1HDAC6
SCHEMBL14011221 0.79 SYK (0.53) CDK2CDK4JAK2HDAC1HDAC6
SCHEMBL8323685 0.78 CDK4 (0.48) CDK2CDK4EIF2AK2
SCHEMBL8324834 0.78 CDK4 (0.56) CDK2CDK4EIF2AK2
SCHEMBL8324564 0.77 CDK4 (0.66) CDK2CDK4EIF2AK2FGFR1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456190-B2 Compositions useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-25 US disclosed
WO-2004083203-A1 COMPOSITIONS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-09-30 WO disclosed